Bow River LLC

16 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

May 2037

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Feb 13 to 22, 2027 · next Feb 13
1 fee due Apr 30, 2027
The maintenance fee for Methods of Treating Cancer (US 11,801,245) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
1 fee due Jul 2, 2027
The maintenance fee for Methods of Treatment (US 11,857,548) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
1 fee due Nov 7, 2027
The maintenance fee for Methods of Treatment (US 11,974,998) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 term has ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,376,507	Method of Treating a Patient with a CYP3A4 Substrate Drug In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence
US 10,857,144	Methods of Treatment In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence
US 11,052,077	Methods of Treating Lung Cancer In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence
US 11,123,346	Methods of Treatment with CYP3A4 Substrate Drugs In force Term ends May 16, 2037 · Low confidence	In force	Term ends May 16, 2037	Low confidence
US 11,154,545	Methods of Treatment In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence
US 11,337,967	Methods of treatment In force Ends no later than May 16, 2037 · From the USPTO record	In force	Ends no later than May 16, 2037	From the USPTO record
US 11,351,160	Methods of Treating Cancer In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence
US 11,491,152	Methods of Treating Lung Cancer with CYP3A4 Substrate Drugs In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence
US 11,730,724	Methods of Treatment In force Term ends May 16, 2037 · Medium confidence	In force	Term ends May 16, 2037	Medium confidence
US 11,801,245	Methods of Treating Cancer In force Term ends May 16, 2037 · High confidence	In force	Term ends May 16, 2037	High confidence

10 of 16 patents shown.

Pro members see all 16.

Pro members: see all 16 patents

Also on record, not counted in the 16: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 4 abandoned

List them